We are live on
!
Find out more
CK
Cohen Klingenstein Portfolio holdings
AUM
$3.49B
1-Year Est. Return
26.65%
This Fund
S&P 500
This Quarter
Est. Return
+5.56%
1 Year Est. Return
+26.65%
3 Year Est. Return
+87.7%
5 Year Est. Return
+104.29%
10 Year Est. Return
+422.19%
AUM
$2.87B
AUM Growth
+$115M
(+4.2%)
Cap. Flow
-$19.6M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
52.63%
Holding
223
New
1
Increased
4
Reduced
38
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street
STT
|
+$219K |
| 2 |
Vanguard Growth ETF
VUG
|
+$26K |
| 3 |
Vanguard Mid-Cap Growth ETF
VOT
|
+$21K |
| 4 |
Bank of America
BAC
|
+$80 |
| 5 |
Pfizer
PFE
|
+$58 |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.24M |
| 2 |
Microsoft
MSFT
|
+$3.42M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$1.34M |
| 4 |
Shell
SHEL
|
+$1.15M |
| 5 |
Hartford Financial Services
HIG
|
+$959K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Financials | 9.89% |
| 3 | Healthcare | 9.72% |
| 4 | Communication Services | 8.54% |
| 5 | Consumer Discretionary | 6.83% |
Similar funds
DILIC
TCM
KCM
ACM
MSC
BCP
PMG
ACA
Cohen Klingenstein's Q3 2024 Portfolio in Review
As of Q3 2024, Cohen Klingenstein held 223 positions worth $2.87B, up 4.2% from $2.76B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 1.8%. Cohen Klingenstein opened 1 new position and exited 3, leaving the 223-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- Cohen Klingenstein's largest Q3 2024 buy was State Street: 2,650 shares worth $234K.
- Cohen Klingenstein added most to Vanguard Growth ETF in Q3 2024, an estimated $26K increase.
- Cohen Klingenstein's biggest Q3 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.24M.
- Cohen Klingenstein fully exited Novartis in Q3 2024, selling an estimated $639K.
- Cohen Klingenstein's ten largest holdings make up 53% of its $2.87B portfolio in Q3 2024.
- Cohen Klingenstein opened 1 new position and closed 3 in Q3 2024.
- Cohen Klingenstein's portfolio value rose 4.2% quarter-over-quarter to $2.87B.
Based on Cohen Klingenstein's 13F filing for Q3 2024, filed 16 Oct 2024.